MKS Inc. Stock Price, News & Analysis

Cognex Corporation (NASDAQ: CGNX) has appointed Dr. John T.C. Lee, CEO of MKS Instruments (NASDAQ: MKSI), to its Board of Directors, effective immediately. Dr. Lee brings extensive experience in leading technology companies and will serve on the Audit Committee and Compensation/Stock Option Committee. His leadership at MKS Instruments, which has nearly $3 billion in annual sales, is expected to add valuable insights to Cognex's strategic direction. Cognex is a leader in the machine vision industry, with over $9 billion in cumulative revenue since its inception in 1981.

MKS Instruments reported a revenue of $742 million for Q1 2022, reflecting a 7% year-over-year increase. GAAP net income rose to $143 million, up 17% year-over-year, while non-GAAP net earnings were $151 million, a 6% increase. The company achieved market leadership in RF Power Supplies and successfully re-syndicated acquisition financing for Atotech Limited. Despite ongoing supply chain challenges, demand remains strong. Revenue guidance for Q2 2022 is set at $730 million, plus or minus $30 million, with expected non-GAAP EPS of approximately $2.28.

MKS Instruments became the global leader in RF Power Supplies in 2021, according to TechInsights. The company saw a 32% year-over-year growth in revenue from its Semiconductor Market, fueled by high demand in its vacuum and photonics portfolios. MKS achieved significant share gains across critical subsystems: nearly 1% in RF Power Supplies, over 2% in RF Power Matching Networks, and more than 3% in Residual Gas Analyzers. The CEO highlighted that success is attributed to focused investments and innovation, ensuring MKS is well positioned for future industry growth.

MKS Instruments (NASDAQ: MKSI) will announce its Q1 2022 financial results on April 26, 2022, after market close. A conference call is scheduled for April 27, 2022, at 8:30 a.m. ET, with participation options available for both domestic and international callers. The company specializes in advanced manufacturing technologies, focusing on sectors such as semiconductor and life sciences. Further details and a live webcast will be accessible on their website.

MKS Instruments (NASDAQ: MKSI) has extended its acquisition agreement with Atotech (NYSE: ATC) until September 30, 2022, to allow for regulatory approvals from China's SAMR. The transaction has received approval from 12 global antitrust authorities. MKS plans to fund the acquisition, valued at approximately $5.1 billion, with available cash and committed debt financing. The acquisition aims to enhance MKS's innovation capabilities by integrating its laser processing technology with Atotech’s chemistry expertise. Recent geopolitical factors have minimal impact on their operations.

MKS Instruments (NASDAQ: MKSI) has announced a quarterly cash dividend of $0.22 per share, set to be paid on March 11, 2022, to stockholders recorded by February 28, 2022. The Board of Directors emphasizes that future dividend declarations will depend on the company's financial conditions and cash availability. MKS Instruments focuses on advanced manufacturing technologies across diverse markets such as semiconductors and life sciences, ensuring productivity improvements for its clients.

MKS Instruments reported a record quarterly revenue of $764 million, marking a 16% year-over-year increase. Non-GAAP net earnings reached $168 million, up 29%, while GAAP net income was $150 million, up 30%. For the full year 2021, revenue hit $2.9 billion, a 27% growth, with annual Non-GAAP net earnings at $634 million (up 54%) and GAAP net income of $551 million (up 57%). The company anticipates continued growth despite supply chain challenges and is optimistic about its acquisition of Atotech Limited.